The company develops regenerative therapies to treat life-threatening diseases. Its product is Stromal cell-Derived Factor-1 , which stimulates the natural healing process by recruiting endothelial progenitor cells to the site of injury.
http://reports.pr-inside.com/new-market-research-report-juventas-therapeutics-r3690567.htm
http://reports.pr-inside.com/new-market-research-report-juventas-therapeutics-r3690567.htm
No comments:
Post a Comment